Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity

Metabolism: Clinical and Experimental

Volumn 61, Issue 5, 2012, Pages 706-714

  Chakaroun, Rima ^a   Raschpichler, Matthias ^a   Klöting, Nora ^a   Oberbach, Andreas ^a   Flehmig, Gesine ^a   Kern, Matthias ^a   Schön, Michael R ^b   Shang, Edward ^a   Lohmann, Tobias ^c   Dreßler, Miriam ^c   Fasshauer, Mathias ^a   Stumvoll, Michael ^a   Blüher, Matthias ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

^c Municipal Clinic Dresden Neustadt   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPOCYTOKINE RECEPTOR; C REACTIVE PROTEIN; MESSENGER RNA; PROTEIN CHEMERIN; PROTEIN CMKLR1; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ARTICLE; BARIATRIC SURGERY; BODY FAT; BODY MASS; CALORIC RESTRICTION; CONTROLLED STUDY; EXERCISE; FEMALE; GENE EXPRESSION; HOMEOSTASIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WEIGHT REDUCTION;

ADIPOSE TISSUE; ADULT; AGED; AGED, 80 AND OVER; BARIATRIC SURGERY; BODY COMPOSITION; CHEMOKINES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIET, REDUCING; EXERCISE; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; OMENTUM; RECEPTORS, CHEMOKINE; REGRESSION ANALYSIS; RNA, MESSENGER; WAIST CIRCUMFERENCE; WEIGHT LOSS; YOUNG ADULT;

EID: 84860253304     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2011.10.008     Document Type: Article

References (26)

1. V. Wittamer, J.D. Franssen, and M. Vulcano Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids J Exp Med 198 2003 977 985
2. B.A. Zabel, S. Nakae, and L. Zúñiga Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis J Exp Med 205 2008 2207 2220
3. J.L. Cash, R. Hart, and A. Russ Synthetic chemerin-derived peptides suppress inflammation through ChemR23 J Exp Med 205 2008 767 775
4. G. Barnea, W. Strapps, and G. Herrada The genetic design of signaling cascades to record receptor activation Proc Natl Acad Sci U S A 105 2008 64 69
5. K. Bozaoglu, K. Bolton, and J. McMillan Chemerin is a novel adipokine associated with obesity and metabolic syndrome Endocrinology 148 2007 4687 4694
6. K.B. Goralski, T.C. McCarthy, and E.A. Hanniman Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism J Biol Chem 282 2007 28175 28188
7. H. Sell, J. Laurencikiene, and A. Taube Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells Diabetes 58 2009 2731 2740
8. M. Becker, K. Rabe, and C. Lebherz Expression of human chemerin induces insulin resistance in the skeletal muscle but does not affect weight, lipid levels, and atherosclerosis in LDL receptor knockout mice on high-fat diet Diabetes 59 2010 2898 2903
9. M.C. Ernst, M. Issa, and K.B. Goralski Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes Endocrinology 151 2010 1998 2007
10. K. Bozaoglu, D. Segal, and K.A. Shields Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population J Clin Endocrinol Metab 94 2009 3085 3088
11. H. Sell, A. Divoux, and C. Poitou Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery J Clin Endocrinol Metab 95 2010 2892 2896
12. J. Weigert, M. Neumeier, and J. Wanninger Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes Clin Endocrinol (Oxf) 72 2010 342 348
13. M. Lehrke, A. Becker, and M. Greif Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis Eur J Endocrinol 161 2009 339 344
14. C. Ress, A. Tschoner, and J. Engl Effect of bariatric surgery on circulating chemerin levels Eur J Clin Invest 40 2010 277 280
15. A. Tönjes, M. Fasshauer, and J. Kratzsch Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes PLoS One 5 2010 e13911
16. N. Klöting, M. Fasshauer, and A. Dietrich Insulin-sensitive obesity Am J Physiol Endocrinol Metab 299 2010 E506 515
17. D. Schleinitz, N. Klöting, and Y. Böttcher Genetic and evolutionary analyses of the human bone morphogenetic protein receptor 2 (BMPR2) in the pathophysiology of obesity PLoS One 6 2011 e16155
18. I. Harman-Boehm, M. Blüher, and H. Redel Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity J Clin Endocrinol Metab 92 2007 2240 2247
19. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care 23 2000 S4 S19
20. M. Blüher, C.J. Williams, and N. Klöting Gene expression of adiponectin receptors in human visceral and subcutaneous adipose tissue is related to insulin resistance and metabolic parameters and is altered in response to physical training Diabetes Care 30 2007 3110 3115
21. M. Blüher, R. Unger, and F. Rassoul Relation between glycaemic control, hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or type II diabetes Diabetologia 45 2002 210 216
22. B.K. Tan, J. Chen, and S. Farhatullah Insulin and metformin regulate circulating and adipose tissue chemerin Diabetes 58 2009 1971 1977
23. H.O. El-Mesallamy, M.O. El-Derany, and N.M. Hamdy Serum omentin-1 and chemerin levels are interrelated in patients with type 2 diabetes mellitus with or without ischaemic heart disease Diabet Med 28 2011 1194 1200
24. M. Yang, G. Yang, and J. Dong Elevated plasma levels of chemerin in newly diagnosed type 2 diabetes mellitus with hypertension J Investig Med 58 2010 883 886
25. M. Blüher Adipose tissue dysfunction in obesity Exp Clin Endocrinol Diabetes 117 2009 241 250
26. M. Takahashi, Y. Takahashi, and K. Takahashi Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes FEBS Lett 582 2008 573 578